Skip to main content
SCLX logo

Scilex Holding Company

SCLXNASDAQHealthcareDrug Manufacturers - General

$2.78Today:- (-)1Y −77.93%

As of Oct 16, 2026 close

Market cap
$19.44M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.79$27.00
Volume (live)
-
Avg. volume (3M)
39.86K

Scilex Holding Company (SCLX) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Scilex Holding Company generated $3.82M of operating cash flow and spent $133.00K on capital expenditures. That left free cash flow of $3.68M, down 80.4% from $18.75M a year earlier, or 12.2% of revenue. It repurchased $27.00M of its own shares.

Scilex Holding Company Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Scilex Holding Company (SCLX) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-374.05-72.81-114.33-23.36-88.42-47.52
Depreciation & Amortization4.624.054.153.963.783.78
Deferred Income Tax0.000.000.000.0012.76-0.80
Stock Based Compensation15.4915.6914.605.285.825.40
Change in Working Capital113.9764.8465.8045.6713.607.06
Change in Accounts Receivable13.84-6.27-13.36-6.97-1.14-0.60
Change in Inventory1.801.46-2.841.18-1.422.38
Change in Accounts Payable13.127.4219.882.81-3.84-4.06
Change in Other Working Capital2.476.488.5727.6219.619.34
Other Operating Activities231.616.488.57-52.8036.560.62
Net Cash from Operating Activities3.8219.35-20.71-21.26-28.66-31.46
Investing Activities
Capital Expenditures-0.13-0.60-0.33-0.010.00-0.03
Acquisitions1.520.000.000.000.000.00
Purchases of Investments-25.91-2.080.000.000.000.00
Sales/Maturities of Investments39.61-0.600.00-2.060.000.00
Other Investing Activities-10.39-0.08-0.300.000.000.00
Net Cash from Investing Activities4.08-2.68-0.33-2.070.00-0.03
Financing Activities
Debt Repayment-21.09-184.65-109.63-103.61-82.22-37.62
Common Stock Issued30.6244.6435.463.470.00-0.09
Common Stock Repurchased-27.00-0.30-10.000.000.000.00
Other Financing Activities-6.04-0.37-3.740.4347.8518.54
Net Cash from Financing Activities-5.46-18.1323.5821.1728.16-19.17
Summary
Effect of Forex Changes on Cash-0.760.000.000.000.000.00
Net Change in Cash1.68-1.462.55-2.15-0.50-50.66
Cash at Beginning of Period3.274.732.184.344.8455.50
Cash at End of Period4.963.274.732.184.344.84
Free Cash Flow3.6818.75-21.04-21.27-28.66-31.49
Supplemental Disclosures
Interest Paid-1.561.43---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Scilex Holding Company Cash Flow

What is Scilex Holding Company's free cash flow?

Scilex Holding Company generated free cash flow of $3.68M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $3.82M minus $133.00K of capital expenditures. That was down 80.4% from $18.75M a year earlier. Free cash flow equaled 12.2% of revenue.

How much does Scilex Holding Company spend on capital expenditures?

Scilex Holding Company spent $133.00K on capital expenditures in fiscal 2025, compared with $600.00K a year earlier. That equals 3.5% of operating cash flow.

Does Scilex Holding Company pay dividends or buy back shares?

Yes. In fiscal 2025 Scilex Holding Company returned $27.00M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition